カテゴリ： GlobalInfoResearch, 世界, 医療/バイオ

世界の全身性アスペルギルス症及び全身性カンジダ症市場2022年：市場規模予測（～2028年）

■ 英語タイトル：Global Systemic Aspergillosis and Systemic Candidasis Market 2022 by Manufacturers, Regions, Type and Application, Forecast to 2028

調査会社GlobalInfoResearch社が発行したリサーチレポート（データ管理コード：GIR22NO19651）■ 発行会社/調査会社：GlobalInfoResearch
■ 商品コード：GIR22NO19651
■ 発行日：2022年11月（※2025年版があります。お問い合わせください。）
■ 調査対象地域：グローバル
■ 産業分野：医薬品
■ ページ数：97
■ レポート言語：英語
■ レポート形式：PDF
■ 納品方式：Eメール（注文後2-3日）
■ 販売価格オプション（消費税別）
Single User（1名様閲覧用）USD3,480 ⇒換算￥528,960見積依頼/購入/質問フォーム
Multi User（20名様閲覧用）USD5,220 ⇒換算￥793,440見積依頼/購入/質問フォーム
Corporate User（同一法人内共有可）USD6,960 ⇒換算￥1,057,920見積依頼/購入/質問フォーム
※販売価格オプションの説明はこちらで、ご購入に関する詳細案内はご利用ガイドでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※Eメールによる納品の場合、通常ご注文当日～2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行・送付致します。（請求書発行日より2ヶ月以内の銀行振込条件、カード払いも可能）
※GlobalInfoResearch社の概要及び新刊レポートはこちらでご確認いただけます。
★グローバルリサーチ資料[世界の全身性アスペルギルス症及び全身性カンジダ症市場2022年：市場規模予測（～2028年）]についてメールでお問い合わせはこちら
*** レポート概要（サマリー）***

全身性アスペルギルス症及び全身性カンジダ症市場レポートは、世界の市場規模、地域および国レベルの市場規模、セグメント市場の成長性、市場シェア、競争環境、販売分析、国内および世界の市場プレーヤーの影響、バリューチェーンの最適化、最近の動向、機会分析、市場成長の戦略的な分析、製品発売、地域市場の拡大などに関する情報を提供します。
GlobalInfoResearchの最新の調査によると、世界の全身性アスペルギルス症及び全身性カンジダ症の市場規模は2021年のxxx米ドルから2028年にはxxx米ドルと推定され、xxx％の成長率で成長すると予想されます。

全身性アスペルギルス症及び全身性カンジダ症市場は種類と用途によって区分されます。2017年～2028年において、量と金額の観点から種類別および用途別セグメントの売上予測データを提供します。この分析は、適格なニッチ市場をターゲットにすることでビジネスを拡大するのに役立ちます。

種類別セグメントは次をカバーします。
・ボリコナゾール、リポソームアムホテリシンB、全身経口アゾール、外用抗真菌剤、その他

用途別セグメントは次のように区分されます。
・CPA、ABPA、消化器カンジダ症、泌尿生殖器カンジダ症、その他

世界の全身性アスペルギルス症及び全身性カンジダ症市場の主要な市場プレーヤーは以下のとおりです。
・Novartis AG、Pfizer, Inc、Sanofi-Aventis、Merck & Co., Inc、Enzon Pharmaceuticals, Inc、Bayer AG、Astellas Pharma, Inc、GlaxoSmithKline plc、Abbott

地域別セグメントは次の地域・国をカバーします。
・北米（米国、カナダ、メキシコ）
・ヨーロッパ（ドイツ、フランス、イギリス、ロシア、イタリア）
・アジア太平洋（日本、中国、韓国、インド、東南アジア、オーストラリア）
・南アメリカ（ブラジル、アルゼンチン、コロンビア）
・中東およびアフリカ（サウジアラビア、UAE、エジプト、南アフリカ）

本調査レポートの内容は計15章あります。
・第1章では、全身性アスペルギルス症及び全身性カンジダ症製品の調査範囲、市場の概要、市場の成長要因・阻害要因、および市場動向について説明します。
・第2章では、主要な全身性アスペルギルス症及び全身性カンジダ症メーカーの企業概要、2019年～2022年までの全身性アスペルギルス症及び全身性カンジダ症の価格、販売量、売上、市場シェアを掲載しています。
・第3章では、主要な全身性アスペルギルス症及び全身性カンジダ症メーカーの競争状況、販売量、売上、世界市場シェアが重点的に比較分析されています。
・第4章では、2017年～2028年までの地域別全身性アスペルギルス症及び全身性カンジダ症の販売量、売上、成長性を示しています。
・第5、6章では、2017年～2028年までの全身性アスペルギルス症及び全身性カンジダ症の種類別と用途別の市場規模、市場シェアと成長率を掲載しています。
・第7、8、9、10、11章では、2017年～2022年までの世界の主要国での販売量、売上、市場シェア、並びに2023年～2028年までの主要地域での全身性アスペルギルス症及び全身性カンジダ症市場予測を収録しています。
・第12章では、主要な原材料、主要なサプライヤー、および全身性アスペルギルス症及び全身性カンジダ症の産業チェーンを掲載しています。
・第13、14、15章では、全身性アスペルギルス症及び全身性カンジダ症の販売チャネル、販売業者、顧客、調査結果と結論、付録、データソースなどについて説明します。

***** 目次(一部) *****

・市場概要
- 全身性アスペルギルス症及び全身性カンジダ症の概要
- 種類別分析（2017年vs2021年vs2028年）：ボリコナゾール、リポソームアムホテリシンB、全身経口アゾール、外用抗真菌剤、その他
- 用途別分析（2017年vs2021年vs2028年）：CPA、ABPA、消化器カンジダ症、泌尿生殖器カンジダ症、その他
- 世界の全身性アスペルギルス症及び全身性カンジダ症市場規模・予測
- 世界の全身性アスペルギルス症及び全身性カンジダ症生産能力分析
- 市場の成長要因・阻害要因・動向
・メーカー情報（企業概要、製品概要、販売量、価格、売上）
- Novartis AG、Pfizer, Inc、Sanofi-Aventis、Merck & Co., Inc、Enzon Pharmaceuticals, Inc、Bayer AG、Astellas Pharma, Inc、GlaxoSmithKline plc、Abbott
・メーカー別市場シェア・市場集中度
・地域別市場分析2017年-2028年
・種類別分析2017年-2028年：ボリコナゾール、リポソームアムホテリシンB、全身経口アゾール、外用抗真菌剤、その他
・用途別分析2017年-2028年：CPA、ABPA、消化器カンジダ症、泌尿生殖器カンジダ症、その他
・全身性アスペルギルス症及び全身性カンジダ症の北米市場
- 種類別市場規模2017年-2028年
- 用途別市場規模2017年-2028年
- 主要国別市場規模：アメリカ、カナダ、メキシコなど
・全身性アスペルギルス症及び全身性カンジダ症のヨーロッパ市場
- 種類別市場規模2017年-2028年
- 用途別市場規模2017年-2028年
- 主要国別市場規模：ドイツ、イギリス、フランス、ロシア、イタリアなど
・全身性アスペルギルス症及び全身性カンジダ症のアジア市場
- 種類別市場規模2017年-2028年
- 用途別市場規模2017年-2028年
- 主要国別市場規模：中国、日本、韓国、インド、東南アジア、オーストラリアなど
・全身性アスペルギルス症及び全身性カンジダ症の南米市場
- 種類別市場規模2017年-2028年
- 用途別市場規模2017年-2028年
- 主要国別市場規模：ブラジル、アルゼンチンなど
・全身性アスペルギルス症及び全身性カンジダ症の中東・アフリカ市場
- 種類別市場規模2017年-2028年
- 用途別市場規模2017年-2028年
- 主要国別市場規模：サウジアラビア、トルコ、エジプト、南アフリカなど
・原材料および産業チェーン
・販売チャネル、流通業者・代理店、顧客リスト
・調査の結果・結論

The Systemic Aspergillosis and Systemic Candidasis market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our (Global Info Research) latest study, due to COVID-19 pandemic, the global Systemic Aspergillosis and Systemic Candidasis market size is estimated to be worth US$ million in 2021 and is forecast to a readjusted size of USD million by 2028 with a CAGR of % during review period. CPA accounting for % of the Systemic Aspergillosis and Systemic Candidasis global market in 2021, is projected to value USD million by 2028, growing at a % CAGR in next six years. While Voriconazole segment is altered to a % CAGR between 2022 and 2028.
Global key manufacturers of Systemic Aspergillosis and Systemic Candidasis include Novartis AG, Pfizer, Inc, Sanofi-Aventis, Merck & Co., Inc, and Enzon Pharmaceuticals, Inc, etc. In terms of revenue, the global top four players hold a share over % in 2021.
Market segmentation
Systemic Aspergillosis and Systemic Candidasis market is split by Type and by Application. For the period 2017-2028, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
Voriconazole
Liposomal Amphotericin B
Systemic Oral Azoles
Topical Antifungal Agents
Other
Market segment by Application can be divided into
CPA
ABPA
Gastrointestinal Candidiasis
Genitourinary Tract Candidiasis
Other
The key market players for global Systemic Aspergillosis and Systemic Candidasis market are listed below:
Novartis AG
Pfizer, Inc
Sanofi-Aventis
Merck & Co., Inc
Enzon Pharmaceuticals, Inc
Bayer AG
Astellas Pharma, Inc
GlaxoSmithKline plc
Abbott
Market segment by region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Systemic Aspergillosis and Systemic Candidasis product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Systemic Aspergillosis and Systemic Candidasis, with price, sales, revenue and global market share of Systemic Aspergillosis and Systemic Candidasis from 2019 to 2022.
Chapter 3, the Systemic Aspergillosis and Systemic Candidasis competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Systemic Aspergillosis and Systemic Candidasis breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2017 to 2028.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2017 to 2028.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2017 to 2022.and Systemic Aspergillosis and Systemic Candidasis market forecast, by regions, type and application, with sales and revenue, from 2023 to 2028.
Chapter 12, the key raw materials and key suppliers, and industry chain of Systemic Aspergillosis and Systemic Candidasis.
Chapter 13, 14, and 15, to describe Systemic Aspergillosis and Systemic Candidasis sales channel, distributors, customers, research findings and conclusion, appendix and data source.

*** レポート目次（コンテンツ）***

1 Market Overview
1.1 Systemic Aspergillosis and Systemic Candidasis Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Systemic Aspergillosis and Systemic Candidasis Revenue by Type: 2017 Versus 2021 Versus 2028
1.2.2 Voriconazole
1.2.3 Liposomal Amphotericin B
1.2.4 Systemic Oral Azoles
1.2.5 Topical Antifungal Agents
1.2.6 Other
1.3 Market Analysis by Application
1.3.1 Overview: Global Systemic Aspergillosis and Systemic Candidasis Revenue by Application: 2017 Versus 2021 Versus 2028
1.3.2 CPA
1.3.3 ABPA
1.3.4 Gastrointestinal Candidiasis
1.3.5 Genitourinary Tract Candidiasis
1.3.6 Other
1.4 Global Systemic Aspergillosis and Systemic Candidasis Market Size & Forecast
1.4.1 Global Systemic Aspergillosis and Systemic Candidasis Sales in Value (2017 & 2021 & 2028)
1.4.2 Global Systemic Aspergillosis and Systemic Candidasis Sales in Volume (2017-2028)
1.4.3 Global Systemic Aspergillosis and Systemic Candidasis Price (2017-2028)
1.5 Global Systemic Aspergillosis and Systemic Candidasis Production Capacity Analysis
1.5.1 Global Systemic Aspergillosis and Systemic Candidasis Total Production Capacity (2017-2028)
1.5.2 Global Systemic Aspergillosis and Systemic Candidasis Production Capacity by Geographic Region
1.6 Market Drivers, Restraints and Trends
1.6.1 Systemic Aspergillosis and Systemic Candidasis Market Drivers
1.6.2 Systemic Aspergillosis and Systemic Candidasis Market Restraints
1.6.3 Systemic Aspergillosis and Systemic Candidasis Trends Analysis
2 Manufacturers Profiles
2.1 Novartis AG
2.1.1 Novartis AG Details
2.1.2 Novartis AG Major Business
2.1.3 Novartis AG Systemic Aspergillosis and Systemic Candidasis Product and Services
2.1.4 Novartis AG Systemic Aspergillosis and Systemic Candidasis Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.2 Pfizer, Inc
2.2.1 Pfizer, Inc Details
2.2.2 Pfizer, Inc Major Business
2.2.3 Pfizer, Inc Systemic Aspergillosis and Systemic Candidasis Product and Services
2.2.4 Pfizer, Inc Systemic Aspergillosis and Systemic Candidasis Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.3 Sanofi-Aventis
2.3.1 Sanofi-Aventis Details
2.3.2 Sanofi-Aventis Major Business
2.3.3 Sanofi-Aventis Systemic Aspergillosis and Systemic Candidasis Product and Services
2.3.4 Sanofi-Aventis Systemic Aspergillosis and Systemic Candidasis Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.4 Merck & Co., Inc
2.4.1 Merck & Co., Inc Details
2.4.2 Merck & Co., Inc Major Business
2.4.3 Merck & Co., Inc Systemic Aspergillosis and Systemic Candidasis Product and Services
2.4.4 Merck & Co., Inc Systemic Aspergillosis and Systemic Candidasis Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.5 Enzon Pharmaceuticals, Inc
2.5.1 Enzon Pharmaceuticals, Inc Details
2.5.2 Enzon Pharmaceuticals, Inc Major Business
2.5.3 Enzon Pharmaceuticals, Inc Systemic Aspergillosis and Systemic Candidasis Product and Services
2.5.4 Enzon Pharmaceuticals, Inc Systemic Aspergillosis and Systemic Candidasis Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.6 Bayer AG
2.6.1 Bayer AG Details
2.6.2 Bayer AG Major Business
2.6.3 Bayer AG Systemic Aspergillosis and Systemic Candidasis Product and Services
2.6.4 Bayer AG Systemic Aspergillosis and Systemic Candidasis Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.7 Astellas Pharma, Inc
2.7.1 Astellas Pharma, Inc Details
2.7.2 Astellas Pharma, Inc Major Business
2.7.3 Astellas Pharma, Inc Systemic Aspergillosis and Systemic Candidasis Product and Services
2.7.4 Astellas Pharma, Inc Systemic Aspergillosis and Systemic Candidasis Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.8 GlaxoSmithKline plc
2.8.1 GlaxoSmithKline plc Details
2.8.2 GlaxoSmithKline plc Major Business
2.8.3 GlaxoSmithKline plc Systemic Aspergillosis and Systemic Candidasis Product and Services
2.8.4 GlaxoSmithKline plc Systemic Aspergillosis and Systemic Candidasis Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.9 Abbott
2.9.1 Abbott Details
2.9.2 Abbott Major Business
2.9.3 Abbott Systemic Aspergillosis and Systemic Candidasis Product and Services
2.9.4 Abbott Systemic Aspergillosis and Systemic Candidasis Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
3 Systemic Aspergillosis and Systemic Candidasis Breakdown Data by Manufacturer
3.1 Global Systemic Aspergillosis and Systemic Candidasis Sales in Volume by Manufacturer (2019, 2020, 2021, and 2022)
3.2 Global Systemic Aspergillosis and Systemic Candidasis Revenue by Manufacturer (2019, 2020, 2021, and 2022)
3.3 Key Manufacturer Market Position in Systemic Aspergillosis and Systemic Candidasis
3.4 Market Concentration Rate
3.4.1 Top 3 Systemic Aspergillosis and Systemic Candidasis Manufacturer Market Share in 2021
3.4.2 Top 6 Systemic Aspergillosis and Systemic Candidasis Manufacturer Market Share in 2021
3.5 Global Systemic Aspergillosis and Systemic Candidasis Production Capacity by Company: 2021 VS 2022
3.6 Manufacturer by Geography: Head Office and Systemic Aspergillosis and Systemic Candidasis Production Site
3.7 New Entrant and Capacity Expansion Plans
3.8 Mergers & Acquisitions
4 Market Analysis by Region
4.1 Global Systemic Aspergillosis and Systemic Candidasis Market Size by Region
4.1.1 Global Systemic Aspergillosis and Systemic Candidasis Sales in Volume by Region (2017-2028)
4.1.2 Global Systemic Aspergillosis and Systemic Candidasis Revenue by Region (2017-2028)
4.2 North America Systemic Aspergillosis and Systemic Candidasis Revenue (2017-2028)
4.3 Europe Systemic Aspergillosis and Systemic Candidasis Revenue (2017-2028)
4.4 Asia-Pacific Systemic Aspergillosis and Systemic Candidasis Revenue (2017-2028)
4.5 South America Systemic Aspergillosis and Systemic Candidasis Revenue (2017-2028)
4.6 Middle East and Africa Systemic Aspergillosis and Systemic Candidasis Revenue (2017-2028)
5 Market Segment by Type
5.1 Global Systemic Aspergillosis and Systemic Candidasis Sales in Volume by Type (2017-2028)
5.2 Global Systemic Aspergillosis and Systemic Candidasis Revenue by Type (2017-2028)
5.3 Global Systemic Aspergillosis and Systemic Candidasis Price by Type (2017-2028)
6 Market Segment by Application
6.1 Global Systemic Aspergillosis and Systemic Candidasis Sales in Volume by Application (2017-2028)
6.2 Global Systemic Aspergillosis and Systemic Candidasis Revenue by Application (2017-2028)
6.3 Global Systemic Aspergillosis and Systemic Candidasis Price by Application (2017-2028)
7 North America by Country, by Type, and by Application
7.1 North America Systemic Aspergillosis and Systemic Candidasis Sales by Type (2017-2028)
7.2 North America Systemic Aspergillosis and Systemic Candidasis Sales by Application (2017-2028)
7.3 North America Systemic Aspergillosis and Systemic Candidasis Market Size by Country
7.3.1 North America Systemic Aspergillosis and Systemic Candidasis Sales in Volume by Country (2017-2028)
7.3.2 North America Systemic Aspergillosis and Systemic Candidasis Revenue by Country (2017-2028)
7.3.3 United States Market Size and Forecast (2017-2028)
7.3.4 Canada Market Size and Forecast (2017-2028)
7.3.5 Mexico Market Size and Forecast (2017-2028)
8 Europe by Country, by Type, and by Application
8.1 Europe Systemic Aspergillosis and Systemic Candidasis Sales by Type (2017-2028)
8.2 Europe Systemic Aspergillosis and Systemic Candidasis Sales by Application (2017-2028)
8.3 Europe Systemic Aspergillosis and Systemic Candidasis Market Size by Country
8.3.1 Europe Systemic Aspergillosis and Systemic Candidasis Sales in Volume by Country (2017-2028)
8.3.2 Europe Systemic Aspergillosis and Systemic Candidasis Revenue by Country (2017-2028)
8.3.3 Germany Market Size and Forecast (2017-2028)
8.3.4 France Market Size and Forecast (2017-2028)
8.3.5 United Kingdom Market Size and Forecast (2017-2028)
8.3.6 Russia Market Size and Forecast (2017-2028)
8.3.7 Italy Market Size and Forecast (2017-2028)
9 Asia-Pacific by Region, by Type, and by Application
9.1 Asia-Pacific Systemic Aspergillosis and Systemic Candidasis Sales by Type (2017-2028)
9.2 Asia-Pacific Systemic Aspergillosis and Systemic Candidasis Sales by Application (2017-2028)
9.3 Asia-Pacific Systemic Aspergillosis and Systemic Candidasis Market Size by Region
9.3.1 Asia-Pacific Systemic Aspergillosis and Systemic Candidasis Sales in Volume by Region (2017-2028)
9.3.2 Asia-Pacific Systemic Aspergillosis and Systemic Candidasis Revenue by Region (2017-2028)
9.3.3 China Market Size and Forecast (2017-2028)
9.3.4 Japan Market Size and Forecast (2017-2028)
9.3.5 Korea Market Size and Forecast (2017-2028)
9.3.6 India Market Size and Forecast (2017-2028)
9.3.7 Southeast Asia Market Size and Forecast (2017-2028)
9.3.8 Australia Market Size and Forecast (2017-2028)
10 South America by Region, by Type, and by Application
10.1 South America Systemic Aspergillosis and Systemic Candidasis Sales by Type (2017-2028)
10.2 South America Systemic Aspergillosis and Systemic Candidasis Sales by Application (2017-2028)
10.3 South America Systemic Aspergillosis and Systemic Candidasis Market Size by Country
10.3.1 South America Systemic Aspergillosis and Systemic Candidasis Sales in Volume by Country (2017-2028)
10.3.2 South America Systemic Aspergillosis and Systemic Candidasis Revenue by Country (2017-2028)
10.3.3 Brazil Market Size and Forecast (2017-2028)
10.3.4 Argentina Market Size and Forecast (2017-2028)
11 Middle East & Africa by Country, by Type, and by Application
11.1 Middle East & Africa Systemic Aspergillosis and Systemic Candidasis Sales by Type (2017-2028)
11.2 Middle East & Africa Systemic Aspergillosis and Systemic Candidasis Sales by Application (2017-2028)
11.3 Middle East & Africa Systemic Aspergillosis and Systemic Candidasis Market Size by Country
11.3.1 Middle East & Africa Systemic Aspergillosis and Systemic Candidasis Sales in Volume by Country (2017-2028)
11.3.2 Middle East & Africa Systemic Aspergillosis and Systemic Candidasis Revenue by Country (2017-2028)
11.3.3 Turkey Market Size and Forecast (2017-2028)
11.3.4 Egypt Market Size and Forecast (2017-2028)
11.3.5 Saudi Arabia Market Size and Forecast (2017-2028)
11.3.6 South Africa Market Size and Forecast (2017-2028)
12 Raw Material and Industry Chain
12.1 Raw Material of Systemic Aspergillosis and Systemic Candidasis and Key Manufacturers
12.2 Manufacturing Costs Percentage of Systemic Aspergillosis and Systemic Candidasis
12.3 Systemic Aspergillosis and Systemic Candidasis Production Process
12.4 Systemic Aspergillosis and Systemic Candidasis Industrial Chain
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.2 Systemic Aspergillosis and Systemic Candidasis Typical Distributors
13.3 Systemic Aspergillosis and Systemic Candidasis Typical Customers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Research Process and Data Source
15.3 Disclaimer

List of Tables
Table 1. Global Systemic Aspergillosis and Systemic Candidasis Revenue by Type, (USD Million), 2017 & 2021 & 2028
Table 2. Global Systemic Aspergillosis and Systemic Candidasis Revenue by Application, (USD Million), 2017 & 2021 & 2028
Table 3. Novartis AG Basic Information, Manufacturing Base and Competitors
Table 4. Novartis AG Major Business
Table 5. Novartis AG Systemic Aspergillosis and Systemic Candidasis Product and Services
Table 6. Novartis AG Systemic Aspergillosis and Systemic Candidasis Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 7. Pfizer, Inc Basic Information, Manufacturing Base and Competitors
Table 8. Pfizer, Inc Major Business
Table 9. Pfizer, Inc Systemic Aspergillosis and Systemic Candidasis Product and Services
Table 10. Pfizer, Inc Systemic Aspergillosis and Systemic Candidasis Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 11. Sanofi-Aventis Basic Information, Manufacturing Base and Competitors
Table 12. Sanofi-Aventis Major Business
Table 13. Sanofi-Aventis Systemic Aspergillosis and Systemic Candidasis Product and Services
Table 14. Sanofi-Aventis Systemic Aspergillosis and Systemic Candidasis Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 15. Merck & Co., Inc Basic Information, Manufacturing Base and Competitors
Table 16. Merck & Co., Inc Major Business
Table 17. Merck & Co., Inc Systemic Aspergillosis and Systemic Candidasis Product and Services
Table 18. Merck & Co., Inc Systemic Aspergillosis and Systemic Candidasis Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 19. Enzon Pharmaceuticals, Inc Basic Information, Manufacturing Base and Competitors
Table 20. Enzon Pharmaceuticals, Inc Major Business
Table 21. Enzon Pharmaceuticals, Inc Systemic Aspergillosis and Systemic Candidasis Product and Services
Table 22. Enzon Pharmaceuticals, Inc Systemic Aspergillosis and Systemic Candidasis Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 23. Bayer AG Basic Information, Manufacturing Base and Competitors
Table 24. Bayer AG Major Business
Table 25. Bayer AG Systemic Aspergillosis and Systemic Candidasis Product and Services
Table 26. Bayer AG Systemic Aspergillosis and Systemic Candidasis Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 27. Astellas Pharma, Inc Basic Information, Manufacturing Base and Competitors
Table 28. Astellas Pharma, Inc Major Business
Table 29. Astellas Pharma, Inc Systemic Aspergillosis and Systemic Candidasis Product and Services
Table 30. Astellas Pharma, Inc Systemic Aspergillosis and Systemic Candidasis Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 31. GlaxoSmithKline plc Basic Information, Manufacturing Base and Competitors
Table 32. GlaxoSmithKline plc Major Business
Table 33. GlaxoSmithKline plc Systemic Aspergillosis and Systemic Candidasis Product and Services
Table 34. GlaxoSmithKline plc Systemic Aspergillosis and Systemic Candidasis Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 35. Abbott Basic Information, Manufacturing Base and Competitors
Table 36. Abbott Major Business
Table 37. Abbott Systemic Aspergillosis and Systemic Candidasis Product and Services
Table 38. Abbott Systemic Aspergillosis and Systemic Candidasis Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 39. Global Systemic Aspergillosis and Systemic Candidasis Sales by Manufacturer (2019, 2020, 2021, and 2022) & (K Units)
Table 40. Global Systemic Aspergillosis and Systemic Candidasis Revenue by Manufacturer (2019, 2020, 2021, and 2022) & (USD Million)
Table 41. Market Position of Manufacturers in Systemic Aspergillosis and Systemic Candidasis, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2021
Table 42. Global Systemic Aspergillosis and Systemic Candidasis Production Capacity by Company, (K Units): 2020 VS 2021
Table 43. Head Office and Systemic Aspergillosis and Systemic Candidasis Production Site of Key Manufacturer
Table 44. Systemic Aspergillosis and Systemic Candidasis New Entrant and Capacity Expansion Plans
Table 45. Systemic Aspergillosis and Systemic Candidasis Mergers & Acquisitions in the Past Five Years
Table 46. Global Systemic Aspergillosis and Systemic Candidasis Sales by Region (2017-2022) & (K Units)
Table 47. Global Systemic Aspergillosis and Systemic Candidasis Sales by Region (2023-2028) & (K Units)
Table 48. Global Systemic Aspergillosis and Systemic Candidasis Revenue by Region (2017-2022) & (USD Million)
Table 49. Global Systemic Aspergillosis and Systemic Candidasis Revenue by Region (2023-2028) & (USD Million)
Table 50. Global Systemic Aspergillosis and Systemic Candidasis Sales by Type (2017-2022) & (K Units)
Table 51. Global Systemic Aspergillosis and Systemic Candidasis Sales by Type (2023-2028) & (K Units)
Table 52. Global Systemic Aspergillosis and Systemic Candidasis Revenue by Type (2017-2022) & (USD Million)
Table 53. Global Systemic Aspergillosis and Systemic Candidasis Revenue by Type (2023-2028) & (USD Million)
Table 54. Global Systemic Aspergillosis and Systemic Candidasis Price by Type (2017-2022) & (USD/Unit)
Table 55. Global Systemic Aspergillosis and Systemic Candidasis Price by Type (2023-2028) & (USD/Unit)
Table 56. Global Systemic Aspergillosis and Systemic Candidasis Sales by Application (2017-2022) & (K Units)
Table 57. Global Systemic Aspergillosis and Systemic Candidasis Sales by Application (2023-2028) & (K Units)
Table 58. Global Systemic Aspergillosis and Systemic Candidasis Revenue by Application (2017-2022) & (USD Million)
Table 59. Global Systemic Aspergillosis and Systemic Candidasis Revenue by Application (2023-2028) & (USD Million)
Table 60. Global Systemic Aspergillosis and Systemic Candidasis Price by Application (2017-2022) & (USD/Unit)
Table 61. Global Systemic Aspergillosis and Systemic Candidasis Price by Application (2023-2028) & (USD/Unit)
Table 62. North America Systemic Aspergillosis and Systemic Candidasis Sales by Country (2017-2022) & (K Units)
Table 63. North America Systemic Aspergillosis and Systemic Candidasis Sales by Country (2023-2028) & (K Units)
Table 64. North America Systemic Aspergillosis and Systemic Candidasis Revenue by Country (2017-2022) & (USD Million)
Table 65. North America Systemic Aspergillosis and Systemic Candidasis Revenue by Country (2023-2028) & (USD Million)
Table 66. North America Systemic Aspergillosis and Systemic Candidasis Sales by Type (2017-2022) & (K Units)
Table 67. North America Systemic Aspergillosis and Systemic Candidasis Sales by Type (2023-2028) & (K Units)
Table 68. North America Systemic Aspergillosis and Systemic Candidasis Sales by Application (2017-2022) & (K Units)
Table 69. North America Systemic Aspergillosis and Systemic Candidasis Sales by Application (2023-2028) & (K Units)
Table 70. Europe Systemic Aspergillosis and Systemic Candidasis Sales by Country (2017-2022) & (K Units)
Table 71. Europe Systemic Aspergillosis and Systemic Candidasis Sales by Country (2023-2028) & (K Units)
Table 72. Europe Systemic Aspergillosis and Systemic Candidasis Revenue by Country (2017-2022) & (USD Million)
Table 73. Europe Systemic Aspergillosis and Systemic Candidasis Revenue by Country (2023-2028) & (USD Million)
Table 74. Europe Systemic Aspergillosis and Systemic Candidasis Sales by Type (2017-2022) & (K Units)
Table 75. Europe Systemic Aspergillosis and Systemic Candidasis Sales by Type (2023-2028) & (K Units)
Table 76. Europe Systemic Aspergillosis and Systemic Candidasis Sales by Application (2017-2022) & (K Units)
Table 77. Europe Systemic Aspergillosis and Systemic Candidasis Sales by Application (2023-2028) & (K Units)
Table 78. Asia-Pacific Systemic Aspergillosis and Systemic Candidasis Sales by Region (2017-2022) & (K Units)
Table 79. Asia-Pacific Systemic Aspergillosis and Systemic Candidasis Sales by Region (2023-2028) & (K Units)
Table 80. Asia-Pacific Systemic Aspergillosis and Systemic Candidasis Revenue by Region (2017-2022) & (USD Million)
Table 81. Asia-Pacific Systemic Aspergillosis and Systemic Candidasis Revenue by Region (2023-2028) & (USD Million)
Table 82. Asia-Pacific Systemic Aspergillosis and Systemic Candidasis Sales by Type (2017-2022) & (K Units)
Table 83. Asia-Pacific Systemic Aspergillosis and Systemic Candidasis Sales by Type (2023-2028) & (K Units)
Table 84. Asia-Pacific Systemic Aspergillosis and Systemic Candidasis Sales by Application (2017-2022) & (K Units)
Table 85. Asia-Pacific Systemic Aspergillosis and Systemic Candidasis Sales by Application (2023-2028) & (K Units)
Table 86. South America Systemic Aspergillosis and Systemic Candidasis Sales by Country (2017-2022) & (K Units)
Table 87. South America Systemic Aspergillosis and Systemic Candidasis Sales by Country (2023-2028) & (K Units)
Table 88. South America Systemic Aspergillosis and Systemic Candidasis Revenue by Country (2017-2022) & (USD Million)
Table 89. South America Systemic Aspergillosis and Systemic Candidasis Revenue by Country (2023-2028) & (USD Million)
Table 90. South America Systemic Aspergillosis and Systemic Candidasis Sales by Type (2017-2022) & (K Units)
Table 91. South America Systemic Aspergillosis and Systemic Candidasis Sales by Type (2023-2028) & (K Units)
Table 92. South America Systemic Aspergillosis and Systemic Candidasis Sales by Application (2017-2022) & (K Units)
Table 93. South America Systemic Aspergillosis and Systemic Candidasis Sales by Application (2023-2028) & (K Units)
Table 94. Middle East & Africa Systemic Aspergillosis and Systemic Candidasis Sales by Region (2017-2022) & (K Units)
Table 95. Middle East & Africa Systemic Aspergillosis and Systemic Candidasis Sales by Region (2023-2028) & (K Units)
Table 96. Middle East & Africa Systemic Aspergillosis and Systemic Candidasis Revenue by Region (2017-2022) & (USD Million)
Table 97. Middle East & Africa Systemic Aspergillosis and Systemic Candidasis Revenue by Region (2023-2028) & (USD Million)
Table 98. Middle East & Africa Systemic Aspergillosis and Systemic Candidasis Sales by Type (2017-2022) & (K Units)
Table 99. Middle East & Africa Systemic Aspergillosis and Systemic Candidasis Sales by Type (2023-2028) & (K Units)
Table 100. Middle East & Africa Systemic Aspergillosis and Systemic Candidasis Sales by Application (2017-2022) & (K Units)
Table 101. Middle East & Africa Systemic Aspergillosis and Systemic Candidasis Sales by Application (2023-2028) & (K Units)
Table 102. Systemic Aspergillosis and Systemic Candidasis Raw Material
Table 103. Key Manufacturers of Systemic Aspergillosis and Systemic Candidasis Raw Materials
Table 104. Direct Channel Pros & Cons
Table 105. Indirect Channel Pros & Cons
Table 106. Systemic Aspergillosis and Systemic Candidasis Typical Distributors
Table 107. Systemic Aspergillosis and Systemic Candidasis Typical Customers
List of Figures
Figure 1. Systemic Aspergillosis and Systemic Candidasis Picture
Figure 2. Global Systemic Aspergillosis and Systemic Candidasis Revenue Market Share by Type in 2021
Figure 3. Voriconazole
Figure 4. Liposomal Amphotericin B
Figure 5. Systemic Oral Azoles
Figure 6. Topical Antifungal Agents
Figure 7. Other
Figure 8. Global Systemic Aspergillosis and Systemic Candidasis Revenue Market Share by Application in 2021
Figure 9. CPA
Figure 10. ABPA
Figure 11. Gastrointestinal Candidiasis
Figure 12. Genitourinary Tract Candidiasis
Figure 13. Other
Figure 14. Global Systemic Aspergillosis and Systemic Candidasis Revenue, (USD Million) & (K Units): 2017 & 2021 & 2028
Figure 15. Global Systemic Aspergillosis and Systemic Candidasis Revenue and Forecast (2017-2028) & (USD Million)
Figure 16. Global Systemic Aspergillosis and Systemic Candidasis Sales (2017-2028) & (K Units)
Figure 17. Global Systemic Aspergillosis and Systemic Candidasis Price (2017-2028) & (USD/Unit)
Figure 18. Global Systemic Aspergillosis and Systemic Candidasis Production Capacity (2017-2028) & (K Units)
Figure 19. Global Systemic Aspergillosis and Systemic Candidasis Production Capacity by Geographic Region: 2022 VS 2028
Figure 20. Systemic Aspergillosis and Systemic Candidasis Market Drivers
Figure 21. Systemic Aspergillosis and Systemic Candidasis Market Restraints
Figure 22. Systemic Aspergillosis and Systemic Candidasis Market Trends
Figure 23. Global Systemic Aspergillosis and Systemic Candidasis Sales Market Share by Manufacturer in 2021
Figure 24. Global Systemic Aspergillosis and Systemic Candidasis Revenue Market Share by Manufacturer in 2021
Figure 25. Systemic Aspergillosis and Systemic Candidasis Market Share by Company Type (Tier 1, Tier 2, and Tier 3) in 2021
Figure 26. Top 3 Systemic Aspergillosis and Systemic Candidasis Manufacturer (Revenue) Market Share in 2021
Figure 27. Top 6 Systemic Aspergillosis and Systemic Candidasis Manufacturer (Revenue) Market Share in 2021
Figure 28. Global Systemic Aspergillosis and Systemic Candidasis Sales Market Share by Region (2017-2028)
Figure 29. Global Systemic Aspergillosis and Systemic Candidasis Revenue Market Share by Region (2017-2028)
Figure 30. North America Systemic Aspergillosis and Systemic Candidasis Revenue (2017-2028) & (USD Million)
Figure 31. Europe Systemic Aspergillosis and Systemic Candidasis Revenue (2017-2028) & (USD Million)
Figure 32. Asia-Pacific Systemic Aspergillosis and Systemic Candidasis Revenue (2017-2028) & (USD Million)
Figure 33. South America Systemic Aspergillosis and Systemic Candidasis Revenue (2017-2028) & (USD Million)
Figure 34. Middle East & Africa Systemic Aspergillosis and Systemic Candidasis Revenue (2017-2028) & (USD Million)
Figure 35. Global Systemic Aspergillosis and Systemic Candidasis Sales Market Share by Type (2017-2028)
Figure 36. Global Systemic Aspergillosis and Systemic Candidasis Revenue Market Share by Type (2017-2028)
Figure 37. Global Systemic Aspergillosis and Systemic Candidasis Price by Type (2017-2028) & (USD/Unit)
Figure 38. Global Systemic Aspergillosis and Systemic Candidasis Sales Market Share by Application (2017-2028)
Figure 39. Global Systemic Aspergillosis and Systemic Candidasis Revenue Market Share by Application (2017-2028)
Figure 40. Global Systemic Aspergillosis and Systemic Candidasis Price by Application (2017-2028) & (USD/Unit)
Figure 41. North America Systemic Aspergillosis and Systemic Candidasis Sales Market Share by Type (2017-2028)
Figure 42. North America Systemic Aspergillosis and Systemic Candidasis Sales Market Share by Application (2017-2028)
Figure 43. North America Systemic Aspergillosis and Systemic Candidasis Sales Market Share by Country (2017-2028)
Figure 44. North America Systemic Aspergillosis and Systemic Candidasis Revenue Market Share by Country (2017-2028)
Figure 45. United States Systemic Aspergillosis and Systemic Candidasis Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 46. Canada Systemic Aspergillosis and Systemic Candidasis Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 47. Mexico Systemic Aspergillosis and Systemic Candidasis Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 48. Europe Systemic Aspergillosis and Systemic Candidasis Sales Market Share by Type (2017-2028)
Figure 49. Europe Systemic Aspergillosis and Systemic Candidasis Sales Market Share by Application (2017-2028)
Figure 50. Europe Systemic Aspergillosis and Systemic Candidasis Sales Market Share by Country (2017-2028)
Figure 51. Europe Systemic Aspergillosis and Systemic Candidasis Revenue Market Share by Country (2017-2028)
Figure 52. Germany Systemic Aspergillosis and Systemic Candidasis Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 53. France Systemic Aspergillosis and Systemic Candidasis Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 54. United Kingdom Systemic Aspergillosis and Systemic Candidasis Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 55. Russia Systemic Aspergillosis and Systemic Candidasis Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 56. Italy Systemic Aspergillosis and Systemic Candidasis Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 57. Asia-Pacific Systemic Aspergillosis and Systemic Candidasis Sales Market Share by Region (2017-2028)
Figure 58. Asia-Pacific Systemic Aspergillosis and Systemic Candidasis Sales Market Share by Application (2017-2028)
Figure 59. Asia-Pacific Systemic Aspergillosis and Systemic Candidasis Sales Market Share by Region (2017-2028)
Figure 60. Asia-Pacific Systemic Aspergillosis and Systemic Candidasis Revenue Market Share by Region (2017-2028)
Figure 61. China Systemic Aspergillosis and Systemic Candidasis Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 62. Japan Systemic Aspergillosis and Systemic Candidasis Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 63. Korea Systemic Aspergillosis and Systemic Candidasis Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 64. India Systemic Aspergillosis and Systemic Candidasis Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 65. Southeast Asia Systemic Aspergillosis and Systemic Candidasis Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 66. Australia Systemic Aspergillosis and Systemic Candidasis Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 67. South America Systemic Aspergillosis and Systemic Candidasis Sales Market Share by Type (2017-2028)
Figure 68. South America Systemic Aspergillosis and Systemic Candidasis Sales Market Share by Application (2017-2028)
Figure 69. South America Systemic Aspergillosis and Systemic Candidasis Sales Market Share by Country (2017-2028)
Figure 70. South America Systemic Aspergillosis and Systemic Candidasis Revenue Market Share by Country (2017-2028)
Figure 71. Brazil Systemic Aspergillosis and Systemic Candidasis Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 72. Argentina Systemic Aspergillosis and Systemic Candidasis Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 73. Middle East & Africa Systemic Aspergillosis and Systemic Candidasis Sales Market Share by Type (2017-2028)
Figure 74. Middle East & Africa Systemic Aspergillosis and Systemic Candidasis Sales Market Share by Application (2017-2028)
Figure 75. Middle East & Africa Systemic Aspergillosis and Systemic Candidasis Sales Market Share by Region (2017-2028)
Figure 76. Middle East & Africa Systemic Aspergillosis and Systemic Candidasis Revenue Market Share by Region (2017-2028)
Figure 77. Turkey Systemic Aspergillosis and Systemic Candidasis Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 78. Egypt Systemic Aspergillosis and Systemic Candidasis Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 79. Saudi Arabia Systemic Aspergillosis and Systemic Candidasis Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 80. South Africa Systemic Aspergillosis and Systemic Candidasis Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 81. Manufacturing Cost Structure Analysis of Systemic Aspergillosis and Systemic Candidasis in 2021
Figure 82. Manufacturing Process Analysis of Systemic Aspergillosis and Systemic Candidasis
Figure 83. Systemic Aspergillosis and Systemic Candidasis Industrial Chain
Figure 84. Sales Channel: Direct Channel vs Indirect Channel
Figure 85. Methodology
Figure 86. Research Process and Data Source


*** 免責事項 ***
https://www.globalresearch.co.jp/disclaimer/
※関連調査資料
  • 全身性アスペルギルス症＆全身性カンジダ症のグローバル市場展望 2023年-2029年：ボリコナゾール、リポソームアムホテリシンB、全身性経口アゾール、局所抗真菌薬、その他
  • 浸透性殺菌剤のグローバル市場展望 2023年-2029年：チオファネートメチル、ポリミキシン、テブコナゾール、その他
  • 世界のイソクスプリン市場2022年：市場規模予測（～2028年）
  • 世界のアセノクマロール市場2022年：市場規模予測（～2028年）
  • 世界のテトラサイクリン市場2022年：市場規模予測（～2028年）
    • ※注目の調査資料
     ※当サイト上のレポートデータは弊社H&Iグローバルリサーチ運営のMarketReport.jpサイトと連動しています。
    ※当市場調査資料(GIR22NO19651 )"世界の全身性アスペルギルス症及び全身性カンジダ症市場2022年：市場規模予測（～2028年）" (英文：Global Systemic Aspergillosis and Systemic Candidasis Market 2022 by Manufacturers, Regions, Type and Application, Forecast to 2028)はGlobalInfoResearch社が調査・発行しており、H&Iグローバルリサーチが販売します。

    ◆H&Iグローバルリサーチのお客様（例）◆


    ※当サイトに掲載していない調査資料も弊社を通してご購入可能ですので、お気軽にご連絡ください。ウェブサイトでは紹介しきれない資料も数多くございます。
    ※無料翻訳ツールをご利用いただけます。翻訳可能なPDF納品ファイルが対象です。ご利用を希望されるお客様はご注文の時にその旨をお申し出ください。